Minoxidil vs Conventional Androgenic Alopecia Treatments
The efficacy of various doses of minoxidil, dutasteride, and finateride for the treatment of male androgenic alopecia (AGA) is evaluated.
Androgenetic Alopecia
Spironolactone Use Not Significantly Associated With Higher Risk for Cancer
The occurrence of cancers in patients who had received spironolactone is evaluated.
Consensus on Trichology Treatments from a Panel of Experts
Dermatologists renowned for their expertise in trichology provided 2 recommendations per area of trichology treatment.
Hair Loss in Women is More Than a Cosmetic Concern
Less than half of women experiencing hair loss have genetic origins as the cause; possible causes and treatments are reviewed.
Androgenetic Alopecia Tied to Impaired HRQoL
The link between androgenetic alopecia (AGA) and health-related quality of life (HRQOL) and psychiatric disorders was examined.
Enzyme Solution Boosts Hair Growth Benefits of Minoxidil in Men With Androgenetic Alopecia
The possible benefits of topical SULT1A1 enzyme as a booster to daily 5% minoxidil treatment for androgenetic alopecia in men is investigated.
Botulinum Toxin May Be Beneficial for Androgenetic Alopecia
Injectable botulinum toxin as a possible adjuvant treatment for patients with androgenetic alopecia was investigated.
Low-Dose Oral Minoxidil Safe for Alopecia
The safety of LDOM for the treatment of hair loss in a large cohort of patients was described.
Intradermal Minoxidil Injections for the Treatment of Androgenetic Alopecia in Women
The efficacy and safety of intradermal injections of 0.5% minoxidil for the treatment of female androgenetic alopecia were evaluated in this novel study.
COVID-19: Baldness in Men May Be Associated With Increased Infection Risk
Men with severe hair loss were significantly more likely to test positive for COVID-19, finds study data.
- Loading...
Loading...
Next post in General Dermatology
Loading... 
Loading...